Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01005459 · ClinicalTrials.gov registry record · Phase 4
Tetracaine Combined Spinal Epidural (CSE) Versus Bupivacaine CSE
A Phase 4 study, sponsored by Wake Forest University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT01005459 is a Phase 4 study that was terminated before completion, run by Wake Forest University. The registered enrollment target is 46 participants.
The verdict
NCT01005459, a Phase 4 study, was terminated before completion, sponsored by Wake Forest University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
The investigators hypothesis is that spinal tetracaine with fentanyl and epinephrine used for CSE labor analgesia volume will last a significantly longer period of time that that of spinal bupivacaine with fentanyl. After informed consent is obtained for the study, subjects meeting criteria when analgesia is requested will be randomized to receive a combined spinal-epidural containing either tetracaine 2 mg with fentanyl and epinephrine or bupivacaine 2 mg with fentanyl and epinephrine.
Interventions
- DRUG Bupivacaine
- DRUG Tetracaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-12-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01005459
The ClinicalTrials.gov registry entry for NCT01005459 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT01005459 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01005459 about?
NCT01005459 is a clinical study titled "Tetracaine Combined Spinal Epidural (CSE) Versus Bupivacaine CSE". The investigators hypothesis is that spinal tetracaine with fentanyl and epinephrine used for CSE labor analgesia volume will last a significantly longer period of time that that of spinal bupivacaine with fentanyl. After informed consent is obtained for the study, subjects meeting criteria when ana...
What is the current status of trial NCT01005459?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2009-08. Estimated completion is 2011-12-12.
What interventions are being tested in trial NCT01005459?
The interventions under investigation include: Bupivacaine (DRUG), Tetracaine (DRUG).
Who is sponsoring clinical trial NCT01005459?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.